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US-English speaking and 16 US-Spanish speaking participants
with primary or secondary insomnia. Data for the validation of
the SIS were collected alongside a North American 4-week multi-
center, double-blind, placebo-controlled, randomized, parallel-
group study in primary and secondary insomnia patients. Item
level analyses including assessment of missing data, item-item
correlations, Principal Components Analysis, and clinical valid-
ity were conducted. Items with ﬂoor or ceiling effects were can-
didates for deletion, as were items which did not load with any
particular domain. Once domains were determined, validity of
the domains was assessed through internal consistency reliability,
item-domain concurrent and divergent validity, clinical validity,
concurrent validity and conﬁrmatory factor analysis. Addition-
ally, responsiveness and minimal important difference estimates
were determined. RESULTS: Patient interviews resulted in
55 items in 8 domains. During item reduction and validation,
18 items were deleted based on their content validity, high
ceiling effect (>40%), redundancy (Inter-item Pearson correla-
tion > 00.80) no or multifactor loading and/or failure to meet the
Item-level discriminant validity criterion. After reduction, the
ﬁnal SIS consists of 35 items in 7 domains. CONCLUSION:
The SIS was developed to account for US-English and US-Spanish
cultural differences. The validation study provides evidence on
the psychometric properties of the SIS. The SIS has been shown
to adequately meet the criteria for a validated measure to be used
in clinical trials.
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OBJECTIVES: To comprehensively explore existing quality of
life (QoL) measures in alcoholism (alcohol abuse and alcohol
dependence). METHODS: Systematic searches of Scopus (1990–
2007) were conducted using terms synonymous with alcoholism
combined with terms associated with measuring QoL. RESULTS:
In total, 618 abstracts were identiﬁed detailing the use of 16
generic patient-reported measures to assess QoL in alcoholism.
Upon further examination (ie searching Scopus using the QoL
measure as a search term from date of development) nine mea-
sured health status and seven assessed generic QoL, with varying
deﬁnitional criteria and domain focus. The SF-36 and EQ-5D, in
particular, have been used widely but frequently misinterpreted
as measures of QoL rather than health status. One alcohol-
speciﬁc QoL measure was identiﬁed; the AlQoL 9, a scale that
the authors have claimed to epitomise alcohol-related QoL.
However, the AlQoL 9 was developed by reducing the SF-36
(French version) to the nine items most relevant to alcoholism.
The methodology for determining the relevance of the existing
items of the SF-36 was comprehensive but the adapted measure
does not include assessment of additional concepts (such as sleep
and social isolation) of particular importance for alcohol-related
QoL. CONCLUSION: There is a lack of research and assessment
of QoL in alcoholism. Individuals need to be given the opportu-
nity to determine the extent to which their QoL is impaired by
alcoholism based upon their own criteria for what constitutes
good QoL. There is a need for an alcoholism-speciﬁc QoL
measure, which focuses on the domains that are most salient to
people with such problems. Furthermore, research that includes
an assessment of the impact of alcoholism on the QoL of friends,
family and colleagues of the person abusing alcohol would also
be valuable. Only then will we be able to assess the full impact of
alcoholism (and its treatment) on QoL.
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OBJECTIVES: Caregivers’s patients with Alzheimer’s disease
(AD) experience physical and psychical stress due to the caring.
This study evaluated the beneﬁts of a Psychosocial Intervention
Program (PIP) on caregivers’ burden METHODS: A epidemio-
logical, prospective, randomized, multicenter study was con-
ducted by psychiatrists who recruited 115 primary caregivers’s of
patients with AD (DMS-IV criteria and MMSE score = 10–26)
and at least 2 impaired instrumental activities of daily living
(IADL score) by Lawton & Brody Test. Caregivers were random-
ized to receive either PIP (intervention group (IG), n = 60) or
standard care (control group (CG), n = 55). PIP consisted on
individual sessions (scheduled every 1–2 weeks during 4 months)
of teaching strategies to reduce caregiver burnout. Caregivers
stress, quality of life (QoL) and perceived health were measured
using validated scales (Zarit, SF-36, GHQ-28) at baseline, after a
4-month and a 10-month follow-up period RESULTS: The
proﬁle of patient with AD was a 77-years-old woman, with
moderate dementia (MMSEscore = 18.74) and high impairment
of daily living activities (mean IADLscore = 2.17). The caregiver
proﬁle was a 60-years-old woman, wife or adult daughter, who is
being careing for 3 years and care daily time was >12 hours,
without refund. Changes in caregiver burden (baseline
Zaritscore–ﬁnal Zaritscore) showed an improvement in the IG
(-8.09 points) and a worsening grouping the CG (+2.08 points),
with statistically signiﬁcance (p = 0.0083). The IG showed sig-
niﬁcant improvements in all the well-being perception areas mea-
sured by the SF-36scores and signiﬁcantly lower score in the
GHQ-28score (p = 0.0004). Caregivers and therapists consid-
ered PIP “useful/very useful” in a 97.7% and 88.6% respectively
at the end of PIP, and in a 93.2% and 86.3% at 6 moths after PIP
ending. CONCLUSION: Caregivers’ psychosocial training can
minimize caregiver distress and may help to develop strategies for
coping problems. PIP improves QoL and the perceived health of
caregivers of patients with AD.
PMH58
IMPROVED SLEEP IMPACT IN GENERALIZED ANXIETY
DISORDER WITH ZOLPIDEMTARTRATE EXTENDED-RELEASE
Crawford B1, Zhu Y1, Seal B2, Rosa K1
1Mapi Values, Boston, MA, USA, 2Sanoﬁ-Aventis, Bridgewater, NJ, USA
OBJECTIVES: Insomnia is frequently associated with general-
ized anxiety disorder (GAD) and affects the patient’s day to day
life. The Sleep Impact Scale (SIS) was developed to assess the
impact of insomnia; however it has not been used in GAD.
Therefore, a study was conducted to validate the SIS and evaluate
the impact of zolpidem tartrate extended-release on insomnia in
GAD. METHODS: Validation and efﬁcacy data of the SIS were
collected alongside a randomized, placebo-controlled trial of
escitalopram + placebo or zolpidem tartrate extended-release in
adults with insomnia associated with GAD. The validation con-
sisted of evaluation of the validity and reliability, the responsive-
ness and the MID of the SIS domains to ensure the questionnaire
was acceptable in a GAD population. The efﬁcacy analysis was
performed on the ITT population, consisting of general linear
models to evaluate changes from baseline at each timepoint, with
study endpoint as the primary change score analysis. Longitudi-
nal analyses were also performed to evaluate the effects of
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